摘要
目的 探讨降纤酶治疗肺心病难治性心衰的临床疗效和安全性。 方法 将 64例肺心病难治性心衰患者随机分为治疗组和对照组 ,全部病例按常规治疗 ,治疗组加用降纤酶 5 u加入 0 .9%氯化钠 15 0 ml中静滴 ,每天 1次 ,监测心功能、血氧饱和度及血液流变学指标 ,取治疗 7天后的临床资料进行评价。 结果 临床总有效率治疗组 90 .6% ,明显高于对照组的 68.8% (χ2 =4.73 ,P <0 .0 5 ) ,无严重不良反应 ,治疗前后心功能、血氧饱和度及血液流变学指标比较 ,治疗组优于对照组 ,两组具有显著或非常显著性差异 (P <0 .0 5或 P <0 .0 1)。 结论 降纤酶能明显改善肺心病难治性心衰患者的心、肺功能 。
Objective To study the effect and safety defibrase treating of chronic Cor pulmonale on retractary heart failure Method 64 cases with chronic Cor pulmonale on retractary heart failure were randomly divided into treated group and control group All patients receivedroutine therapy,defibrase 5u in 0 9% NaCl Normal saline 150ml intraveinous dripqd plus treated group Clinical outcomes were evaluated 7 days,heart on functionSaram Oxgen strength and Sarum,lipids hemorheology Were before and after the treatment Result Clinical effecacy and total rateis 90 6 per cent 68 8(χ 2=4 73,P<0 05) treated group obrious side there found no adverse reactionsrelated to the drug differernces indexes improve heart on function and Sarum Oxgenstrength and Sarum lipids hmorheology were obvious or veng obvions side(P<0 05 or P<0 01) Conclusion Defibrase which pathe way of improve the chronic cor pulmonale on retractary heart failure patients of heart and pulmonale function in patientswith obvious side effects and safecy
出处
《蛇志》
2002年第2期15-17,共3页
Journal of Snake